These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 9751114)

  • 1. Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.
    Liu LN; Dias P; Houghton PJ
    Cell Growth Differ; 1998 Sep; 9(9):699-711. PubMed ID: 9751114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
    Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
    Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
    Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin.
    Katagiri T; Akiyama S; Namiki M; Komaki M; Yamaguchi A; Rosen V; Wozney JM; Fujisawa-Sehara A; Suda T
    Exp Cell Res; 1997 Feb; 230(2):342-51. PubMed ID: 9024793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle regulatory factor MRF4 activates differentiation in rhabdomyosarcoma RD cells through a positive-acting C-terminal protein domain.
    Sirri V; Leibovitch MP; Leibovitch SA
    Oncogene; 2003 Aug; 22(36):5658-66. PubMed ID: 12944914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that E-box promoter elements and MyoD transcription factors play a role in the induction of cathepsin B gene expression during human myoblast differentiation.
    Jane DT; Morvay LC; Koblinski J; Yan S; Saad FA; Sloane BF; Dufresne MJ
    Biol Chem; 2002 Dec; 383(12):1833-44. PubMed ID: 12553720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular cardiomyoplasty of cardiac fibroblasts by adenoviral delivery of MyoD ex vivo: an unlimited source of cells for myocardial repair.
    Etzion S; Barbash IM; Feinberg MS; Zarin P; Miller L; Guetta E; Holbova R; Kloner RA; Kedes LH; Leor J
    Circulation; 2002 Sep; 106(12 Suppl 1):I125-30. PubMed ID: 12354721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated cyclins and cyclin-dependent kinase activity in the rhabdomyosarcoma cell line RD.
    Knudsen ES; Pazzagli C; Born TL; Bertolaet BL; Knudsen KE; Arden KC; Henry RR; Feramisco JR
    Cancer Res; 1998 May; 58(9):2042-9. PubMed ID: 9581851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of phase limited inhibition of MyoD expression on the terminal differentiation of bovine myoblasts: no alteration of Myf5 or myogenin expression.
    Muroya S; Nakajima I; Oe M; Chikuni K
    Dev Growth Differ; 2005 Sep; 47(7):483-92. PubMed ID: 16179075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia affects positively the proliferation of bovine satellite cells and their myogenic differentiation through up-regulation of MyoD.
    Kook SH; Son YO; Lee KY; Lee HJ; Chung WT; Choi KC; Lee JC
    Cell Biol Int; 2008 Aug; 32(8):871-8. PubMed ID: 18468460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MyoD induces apoptosis in the absence of RB function through a p21(WAF1)-dependent re-localization of cyclin/cdk complexes to the nucleus.
    Peschiaroli A; Figliola R; Coltella L; Strom A; Valentini A; D'Agnano I; Maione R
    Oncogene; 2002 Nov; 21(53):8114-27. PubMed ID: 12444547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SV40 T antigen inhibits expression of MyoD and myogenin, up-regulates Myf-5, but does not affect early expression of desmin or alpha 7 integrin during muscle development.
    Haider SR; Wang W; Kaufman SJ
    Exp Cell Res; 1994 Feb; 210(2):278-86. PubMed ID: 7507852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
    Grasberger H; Ye H; Mashima H; Bell GI
    Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MyoD induces the expression of p57Kip2 in cells lacking p21Cip1/Waf1: overlapping and distinct functions of the two cdk inhibitors.
    Figliola R; Maione R
    J Cell Physiol; 2004 Sep; 200(3):468-75. PubMed ID: 15254975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylated myoblasts specifically deficient in MyoD autoactivation as a consequence of instability of MyoD.
    Horwitz M
    Exp Cell Res; 1996 Jul; 226(1):170-82. PubMed ID: 8660953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MyoD(-/-) satellite cells in single-fiber culture are differentiation defective and MRF4 deficient.
    Cornelison DD; Olwin BB; Rudnicki MA; Wold BJ
    Dev Biol; 2000 Aug; 224(2):122-37. PubMed ID: 10926754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transactivation of cardiac MLC-2 promoter by MyoD in 10T1/2 fibroblast cells is independent of E-box requirement but depends upon new proteins that recognize MEF-2 site.
    Goswami SK; Siddiqui MA
    Cell Mol Biol Res; 1995; 41(3):199-205. PubMed ID: 8589760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle-specific transcription factors in fibroblasts expressing the alpha-striated tropomyosin 3' untranslated region.
    L'ecuyer TJ; Schutte BC; Mendel KA; Morris E; Fulton AB
    Mol Genet Metab; 1999 Jul; 67(3):213-26. PubMed ID: 10381329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The involvement of proteasome in myogenic differentiation of murine myocytes and human rhabdomyosarcoma cells.
    Mugita N; Honda Y; Nakamura H; Fujiwara T; Tanaka K; Omura S; Shimbara N; Ogawa M; Saya H; Nakao M
    Int J Mol Med; 1999 Feb; 3(2):127-37. PubMed ID: 9917519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MyoD cannot compensate for the absence of myogenin during skeletal muscle differentiation in murine embryonic stem cells.
    Myer A; Olson EN; Klein WH
    Dev Biol; 2001 Jan; 229(2):340-50. PubMed ID: 11203698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.